Hope for lasting weight control in rare genetic obesity

NCT ID NCT06596135

Summary

This study continues testing setmelanotide, a medication for rare genetic obesity conditions, to check its long-term safety. It includes patients aged 2 and older who benefited from the drug in earlier trials. The main goal is to monitor side effects over an extended treatment period.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY ASSOCIATED WITH DEFECTS IN LEPTIN-MELANOCORTIN PATHWAY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Children's Minnesota

    Saint Paul, Minnesota, 55102, United States

  • Geisinger Health System

    Danville, Pennsylvania, 17821, United States

  • HonorHealth Research Institute

    Scottsdale, Arizona, 85258, United States

  • M3 Wake Research, Inc

    Raleigh, North Carolina, 27612, United States

  • Marshfield Clinical Research Institute

    Marshfield, Wisconsin, 54449, United States

  • Mayo Clinic - Rochester

    Rochester, Minnesota, 55905, United States

  • Seattle Children's Research Institute

    Seattle, Washington, 98105, United States

  • UC San Diego- Rady Children's Hospital

    San Diego, California, 92123, United States

  • University of Buffalo

    Getzville, New York, 14068, United States

  • University of Florida at Gainesville

    Gainesville, Florida, 32611, United States

  • University of Michigan

    Ann Arbor, Michigan, 48109, United States

  • Vanderbilt University School of Medicine

    Nashville, Tennessee, 37232, United States

  • WR-ClinSearch

    Chattanooga, Tennessee, 37421, United States

Conditions

Explore the condition pages connected to this study.